Home » Authors » Omar Ford

Articles by Omar Ford

Simulation: unproven, costly but beginning to gain traction

Oct. 25, 2007

ExThera formed to treat sepsis as latest device/drug matchup

Oct. 22, 2007

Virtual Companies Project used to boost Michigan's economy

Oct. 16, 2007

In $42M buy, QLT has ForSight to address glaucoma patients

Oct. 10, 2007

Apollo in ‘A’ $11.5 million round; Simplex Diabetic garners $50M

Oct. 9, 2007

Panelist: ‘Focus’ essential for medical device start ups

Oct. 8, 2007

Med-tech landscape is sunny, but watch out for ‘storm clouds’

Oct. 5, 2007

Spectranetics launches PATENT trial for SFA instent restenosis

Oct. 3, 2007

Calcification attack, but adjacent tissue safety via Diamondback

Oct. 1, 2007

Product briefs: Digital Health wins PMA for Retasure retinopathy detection

Oct. 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...